Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Cisplatin vs FOLFOX6 in Locally Advanced Gastric Cancer
NCT01889303Phase 2Unknown
- Sponsor
- Wuhan University
- Start
- May 2013
- Primary completion
- Jun 2023
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, Cisplatin micelle injection (HA132) in gastric cancer (GC), sponsored by Wuhan University. Status: unknown.
02
Drugs
docetaxelCisplatin micelle injection (HA132)
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01889303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01889303.